4/A: Processa Pharmaceuticals Amends Insider Ownership Filing
Amendment to Insider Ownership Report
Processa Pharmaceuticals' Chief Administrative Officer, Wendy Guy, filed an amendment to retract a previously filed Form 4 regarding beneficial ownership.
Summary
- Wendy Guy, Chief Administrative Officer of Processa Pharmaceuticals, Inc. (PCSA), filed an amendment (Form 4/A) to retract a previously submitted Form 4.
- The original Form 4 was filed in error and is now being formally withdrawn.
- Beneficial ownership of common stock for Wendy Guy includes 26,339 shares held directly and 8,335 shares held indirectly through CorLyst, LLC.
Sentiment
Score: 5
Explanation: Neutral, as this is an administrative correction of a previous filing error, indicating no new material information regarding company performance or insider transactions beyond the correction itself.
Management Comments
- Amendment filed to retract the prior Form 4, which was filed in error.
Stakeholder Impact
- Shareholders: Provides updated and corrected information regarding insider beneficial ownership, ensuring transparency and accuracy in regulatory disclosures.
Key Dates
| Date | Description |
|---|---|
| 07/24/2025 | Date of earliest transaction as reported in the original, now retracted, Form 4. |
| 07/28/2025 | Date the original Form 4, which is now being amended, was filed. |
| 09/18/2025 | Date of signature for the current Form 4/A amendment filing. |
Keywords
Processa Pharmaceuticals, PCSA, Wendy Guy, Form 4/A, Insider Ownership, SEC Filing, Amendment, Chief Administrative Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.